Enfusion Inc. Q3 2024 Earnings Report

Enfusion Inc. (Ticker: ENFN), a leading provider of investment management software solutions, reported a successful third quarter in 2024. Key financials include:

• Revenue: $51.2 million, a 15% year-over-year increase.
• Adjusted EBITDA: $11.1 million, representing a 21.8% margin.
• Annual Recurring Revenue (ARR): Surpassed $200 million, with a 14% year-over-year increase.
• Net Dollar Retention (NDR): Steady at 102%.

Key Takeaways

• Client Growth: Signed 38 new clients, totaling 894, with an average total value (ATV) of $229,000, up 5.7% YoY.
• Regional Revenue Growth:
  • Americas: 17%
  • EMEA: 22%
  • Asia-Pacific: 6%
• 2024 Guidance: Tightened revenue guidance to $202-$205 million and EBITDA guidance to $41-$45 million.

Company Outlook

• Management is confident in achieving medium-term revenue growth targets of 20%-22% from 2025-2027, with consistent margins.
• Free cash flow conversion remains projected at 50%-55%.
• Stock-based compensation expected between $19 million and $20 million for 2024.

Bearish Highlights

• Moderation in back book growth.
• Slight deceleration in ARR growth below 30%.

Bullish Highlights

• Strong U.S. launch market and record EMEA client bookings in Q3.
• 32% of new clients from non-core markets.

Misses

• Lack of details on ARR growth deceleration.

Q&A Highlights

• Management engaged with third-party consultants for market expansion.
• NDR has stabilized with expectations for slight improvements.

Investments and Insights

Enfusion's tight focus on product innovation and market expansion has resulted in a notable increase in client acquisitions and enhancement of its product suite, signaling future growth potential despite some market challenges.

Summary of Financial Performance

• Revenue: $51.2 million (up 15% YoY)
• Adjusted EBITDA: $11.1 million (21.8% margin)
• ARR: $202.7 million (up 14% YoY)